Market closedNon-fractional
McKesson/MCK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About McKesson
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Ticker
MCK
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Providers and Services
Headquarters
Irving, United States
Employees
48,000
Website
www.mckesson.com
McKesson Metrics
BasicAdvanced
$77B
Market cap
26.61
P/E ratio
$22.39
EPS
0.47
Beta
$2.40
Dividend rate
0.40%
Dividend yield
Price and volume
Market cap
$77B
Beta
0.47
Dividend rate
$2.40
Financial strength
Current ratio
0.916
Quick ratio
0.501
Long term debt to equity
-440.588
Total debt to equity
-462.164
Dividend payout ratio (TTM)
10.46%
Interest coverage (TTM)
15.54%
Management effectiveness
Return on assets (TTM)
4.41%
Return on equity (TTM)
-204.60%
Valuation
Price to earnings (TTM)
26.607
Price to revenue (TTM)
0.257
Price to book
-39.2
Price to tangible book (TTM)
-5.25
Price to free cash flow (TTM)
21.878
Dividend yield (TTM)
0.40%
Growth
Revenue change (TTM)
11.65%
Earnings per share change (TTM)
-10.54%
3-year revenue growth (CAGR)
9.05%
3-year earnings per share growth (CAGR)
-7.47%
3-year dividend per share growth (CAGR)
12.85%
What the Analysts think about McKesson
Analyst Ratings
Majority rating from 19 analysts.
McKesson Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$76B
-5.62%
Net income
$791M
34.30%
Profit margin
1.03%
43.06%
McKesson Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
$7.27
$6.23
$7.74
$6.18
-
Expected
$5.87
$6.15
$7.05
$6.34
$7.23
Surprise
23.94%
1.33%
9.82%
-2.59%
-
McKesson News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for McKesson stock?
McKesson (MCK) has a market cap of $77B as of July 27, 2024.
What is the P/E ratio for McKesson stock?
The price to earnings (P/E) ratio for McKesson (MCK) stock is 26.61 as of July 27, 2024.
Does McKesson stock pay dividends?
Yes, the McKesson (MCK) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $2.4 and the yield is 0.4%. McKesson has a payout ratio of 10.46% on a trailing twelve-month basis.
When is the next McKesson dividend payment date?
The next McKesson (MCK) dividend payment date is unconfirmed.
What is the beta indicator for McKesson?
McKesson (MCK) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell McKesson stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.